Trinity J Bivalacqua MD PhD
Male Sexual Dysfunction, Surgical Oncology
Professor of Urology and Oncology, University of Pennsylvania, Abramson Cancer Center at Penn
Join to view full profile
3400 Civic Center Blvd# WPhiladelphia, PA 19104
Phone+1 215-662-2891
Fax+1 215-662-6734
Dr. Bivalacqua is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Trinity Bivalacqua is an urologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. He received his medical degree from Tulane University School of Medicine and has been in practice 13 years. He specializes in male sexual dysfunction and surgical oncology and is experienced in prostate cancer, urologic oncology, erectile dysfunction, bladder cancer, and penile cancer.
Education & Training
Johns Hopkins UniversityResidency, Urology, 2005 - 2010- Johns Hopkins University School of MedicineInternship, Transitional Year, 2004 - 2005
Tulane University School of MedicineClass of 2004
Certifications & Licensure
PA State Medical License 2021 - 2026
NJ State Medical License 2023 - 2025
MD State Medical License 2009 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- The effect of neonatal partial upper and lower urinary tract obstruction on the intestinal microbiome in a murine animal model.Nora H Broadwell, Kara Lombardo, Taylor P Kohn, Charlotte Q Wu, Max R Kates
Journal of Pediatric Urology. 2026-10-01 - Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Y...Tyler S Garman, Soum Lokeshwar, Jack Campbell, Zhuo Tony Su, Andrew T Gabrielson
The Journal of Urology. 2026-10-01 - Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.Patrick J Hensley, Jeremy Y C Teoh, Roger Li, Shilpa Gupta, Laura Bukavina
Nature Reviews. Urology. 2026-08-05
Journal Articles
- Original Contribution Targeted Sequencing of Plasmacytoid Urothelial Carcinoma Reveals Frequent TERT Promoter Mutations☆Morgan Cowan, Bert Vogelstein, Trinity J Bivalacqua, Gunes Guner, ScienceDirect
- Hospitalization and Readmission Costs After Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter?Hiten D Patel, Meera R Chappidi, Trinity J Bivalacqua, Gregory A Joice, Phillip M Pierorazio, Max Kates, Nikolai A Sopko, BJU International
Authored Content
- Intratunical Injection of Stromal Vascular Fraction Prevents Fibrosis in a Rat Model of Peyronie's DiseaseSeptember 2018
- Recommendations for Follow-up of Muscle-Invasive Bladder Cancer Patients: A Consensus by the International Bladder Cancer NetworkFebruary 2018
Press Mentions
‘Restorative’ Treatments for Erectile Dysfunction Aren’t Proven to Work. Men Pay Thousands AnywayNovember 30th, 2021- AUA, SMSNA Release New Acute Ischemic Priapism GuidelineSeptember 9th, 2021
- World NewsDecember 26th, 2020
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/trinity-bivalacqua
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
